Miami Cancer Institute to Host Seventh Annual Global Summit on Immunotherapies for Hematologic Malignancies
MIAMI, FL – December 15, 2025 — Miami Cancer Institute, part of Baptist Health South Florida, today announced it will host the Seventh Annual Global Summit on Immunotherapies for Hematologic Malignancies on March 6–7, 2026, at the JW Marriott Miami.
The 2026 symposium will focus on the latest advances in the immunotherapy landscape for leukemia, lymphoma and multiple myeloma. The symposium will highlight emerging molecular- and immune-based treatments, evolving therapeutic strategies, the rationale behind new diagnostic and therapeutic modalities, and the role and timing of hematopoietic cell transplantation and immunotherapy combinations.
“The rapidly evolving landscape of immunotherapy demands an informed, multidisciplinary approach,” said Guenther Koehne, M.D., Ph.D., Founder of the Summit, Deputy Director of Miami Cancer Institute and Chief of Stem Cell Transplantation & Hematologic Oncology. “Our 2026 Summit is designed to convene leading experts and practitioners to review best practices, novel therapeutic strategies and the latest data, all to help improve outcomes for patients with hematologic malignancies.”
The symposium will feature comprehensive updates on novel immunotherapies for multiple myeloma, lymphomas and leukemias, including advances in novel agents and cellular therapies. Attendees will benefit from in-depth discussions on the integration of immunotherapy with transplantation, as well as emerging combination treatment strategies. The program also includes expert-led sessions, case reviews and interactive panels that address real-world challenges in managing hematologic cancers. Continuing medical education (CME/CE) credit will be offered to participating healthcare professionals.
This educational summit is intended for hematologists, oncologists, pathologists, radiation oncologists, palliative care providers, oncology and hematology nurses, pharmacists, and other allied health-care professionals engaged in the care of patients with hematologic malignancies.
Registration is now open and early-registration discounts apply through February 6, 2026. For details, fees, and group-discount options, visit the symposium registration page at Miami Cancer Institute Immunotherapies Summit for Hematologic Malignancies, Seventh Annual | Baptist Health CME.
For updates about Miami Cancer Institute’s Seventh Annual Global Summit on Immunotherapies for Hematologic Malignancies, follow Baptist Health Cancer Care on X (Twitter) at @BHCancerCare.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://cancer.baptisthealth.net/miami-cancer-institute.
Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.
